Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123425464 | 12342546 | 4 | F | 201601 | 20160708 | 20160506 | 20160719 | EXP | CN-GLAXOSMITHKLINE-CN2016063592 | GLAXOSMITHKLINE | 47.00 | YR | M | Y | 0.00000 | 20160719 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123425464 | 12342546 | 1 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 300 MG, QD | 0 | 300 | MG | TABLET | QD | ||||||
| 123425464 | 12342546 | 2 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, QOD | 0 | 1 | DF | TABLET | QOD | ||||||
| 123425464 | 12342546 | 3 | SS | ADEFOVIR DIPIVOXIL. | ADEFOVIR DIPIVOXIL | 1 | Unknown | UNK | N | U | 0 | TABLET | |||||||
| 123425464 | 12342546 | 4 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | N | U | 21003 | ||||||||
| 123425464 | 12342546 | 5 | SS | TELBIVUDINE | TELBIVUDINE | 1 | Oral | 1 DF, QD | N | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123425464 | 12342546 | 1 | Hepatitis B |
| 123425464 | 12342546 | 3 | Hepatitis B |
| 123425464 | 12342546 | 4 | Hepatitis B |
| 123425464 | 12342546 | 5 | Hepatitis B |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123425464 | 12342546 | OT |
| 123425464 | 12342546 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123425464 | 12342546 | Blood creatine phosphokinase increased | |
| 123425464 | 12342546 | Drug tolerance | |
| 123425464 | 12342546 | Hepatic cirrhosis | |
| 123425464 | 12342546 | Inappropriate schedule of drug administration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123425464 | 12342546 | 5 | 20160416 | 0 |